Home arrow Latest News
News
Date Item Title
Saturday, 16 August 2008 TriMark Stem Cell Conference 2008
Thursday, 14 August 2008 Market Research Update W33 2008
Wednesday, 13 August 2008 TriMark Molecular Diagnostics Conference 2008
Wednesday, 06 August 2008 Is drug lifecycle management the answer to the $100billion question?
Thursday, 31 July 2008 Expert Views: Biovest/Accentia's BiovaxID revives hope for therapeutic cancer vaccines
Tuesday, 29 July 2008 Market Research Update W31 2008
Thursday, 24 July 2008 Expert Views: Roche looks to maximize Genentech potential
Wednesday, 16 July 2008 A shot against the superbug - immunization against S. aureus has big potential in selected target
Thursday, 26 June 2008 Expert Views: Can technology diminish reliance on heart transplants?
Wednesday, 25 June 2008 Market Research Update W29 2008
Tuesday, 24 June 2008 Market Research Update W27 2008
Thursday, 19 June 2008 Expert Views: Inhaler devices are still a major hurdle in asthma and COPD treatment
Tuesday, 17 June 2008 Market Research Update W25 2008
Thursday, 12 June 2008 Expert Views: 'Conservative' pharmaceutical industry slow to take advantage of online marketing oppo
Friday, 06 June 2008 Expert Views: Pharmacovigilance solutions: essential for the future of healthcare
Thursday, 05 June 2008 Market Research Update W23 2008
Thursday, 05 June 2008 Predictive and Proactive Pharmacovigilance Paves the Road for Drug Safety Solutions
Wednesday, 04 June 2008 Inhaler devices are still a major hurdle in asthma and COPD treatment
Thursday, 29 May 2008 Expert Views: Drug distribution restricted as manufacturers attempt to guard supply chain
Wednesday, 21 May 2008 Lung cancer epidemic looming in Asia?
Tuesday, 20 May 2008 Market Research Update W21 2008
Wednesday, 14 May 2008 Bone metastases: can you teach an old drug new tricks?
Thursday, 08 May 2008 Expert Views: Can biologic drugs tackle antibiotic resistance?
Wednesday, 07 May 2008 Pharma moving to more restricted drug distribution, in attempt to guard drug supply chain
Tuesday, 06 May 2008 Market Research Update W19 2008
Wednesday, 23 April 2008 Market Research Update W17 2008
Wednesday, 23 April 2008 ‘Conservative’ Pharma slow to take advantage of online marketing opportunities
Thursday, 17 April 2008 Cash-strapped Govts, patent expiries fuel generics growth
Thursday, 17 April 2008 Expert Views: Novartis eyes Alcon to drive diversification strategy
Thursday, 17 April 2008 Aldagen initiates Phase III trial for metabolic diseases
Thursday, 17 April 2008 Celldex reports tumor-specific immune response in Phase II glioblastoma trial
Thursday, 10 April 2008 Pharma must adapt to changing market dynamics in 2008
Tuesday, 08 April 2008 Market Research Update W15 2008
Friday, 04 April 2008 Expert Views: Pfizer: tremelimumab Phase III melanoma trial halted
Thursday, 20 March 2008 Expert Views: Big Pharma rushing for foothold in emerging markets despite challenges
Wednesday, 19 March 2008 Market Research Update W12 2008
Thursday, 13 March 2008 Expert Views: Licensing not always the panacea for Pharma's ills
Thursday, 13 March 2008 ACT and Catholic Healthcare West sign clinical trial agreement
Thursday, 13 March 2008 Avexa's apricitabine found effective in Phase II HIV trial
Thursday, 13 March 2008 CombinatoRx reports positive Phase II results of psoriasis drug
Thursday, 13 March 2008 M's Science and Eisai sign option agreement for CNS drug
Tuesday, 04 March 2008 Market Research Update W10 2008
Friday, 29 February 2008 Expert Views: Alcoholism drug market: shift in disease perception required for long-term growth
Friday, 29 February 2008 APP Pharma granted approval for generic anticancer drug
Friday, 29 February 2008 Athersys reports encouraging Phase I results of obesity drug
Friday, 29 February 2008 Covidien granted tentative approval for generic myocardial kit
Friday, 29 February 2008 Integra launches skull pins for brain surgery
Friday, 22 February 2008 Expert Views: HbA1c: how low should you go?
Friday, 22 February 2008 Algeta to initiate US clinical trials for prostate cancer drug
Friday, 22 February 2008 Bionovo's breast cancer drug shows tolerability at higher doses

© 2008 BioMarket Group